Grant Title

DFC Support Program – National Community Anti-Drug Coalition Institute (NCI)

Link

Grant Details

Grant Number

NCI-NCI-24-001

Grant Funder

National Community Anti-Drug Coalition Institute (NCI)

Current or Forecasted

Current

Funding Type

Grant

Funding Amounts

$2,500,000 per year

Expected Number of Awards

One

Due Date

September 16, 2024

Award Date

Period of Performance

September 1, 2024 to August 31, 2025

Description

The award will support the primary goals of the NCI, which are to: 1) increase the percentage of community coalitions across the United States that are effective in their work; and 2) strengthen technical assistance and training to community coalitions throughout the United States and territories.

Eligibility

ONDCP encourages applications from any national nonprofit organization that represents, provides technical assistance and training to, and has special expertise and broad, national-level experience in community anti-drug coalitions under section 1032 of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1532). See Public Law 115-271, 132 Stat. 4112 § 8204 (codified as amended at Subsection “(b) Eligible Organizations” in 21 U.S.C. 1521 Note).

Grant Title

Ending the HIV Epidemic in the U.S. – Ryan White HIV/AIDS Program Parts A and B

Link

Grant Details

Grant Number

HRSA-25-063

Grant Funder

Health Resources & Services Administration (HRSA)

Current or Forecasted

Current

Funding Type

Cooperative agreement

Funding Amounts

$2,200,000 to $30,200,000

Expected Number of Awards

47

Due Date

October 22, 2024

Award Date

February 1, 2025

Period of Performance

March 1, 2025 to February 28, 2030

Description

The purpose of this initiative is to focus resources in 48 counties, Washington, D.C., San Juan, Puerto Rico (PR), and seven states with the highest incidence or burden of HIV to implement effective and innovative strategies, interventions, approaches, and services to reduce new HIV infections in the United States. The Ending the HIV Epidemic in the U.S. (hereafter referred to as the “EHE initiative”) focuses on four key strategies:

• Diagnose all people with HIV as early as possible;
• Treat people with HIV rapidly and effectively to reach sustained viral suppression;
• Prevent new HIV transmissions by using proven interventions; and
• Respond quickly to potential HIV outbreaks to get needed prevention and treatment services to people who need them.

HRSA and the Centers for Disease Control and Prevention (CDC), along with the National Institutes of Health (NIH) Centers for AIDS Research (CFARs), the Indian Health Service (IHS), Department of Housing and Urban Development (HUD), and the Substance Abuse and Mental Health Services Administration (SAMHSA) are collaborating on implementation of these key strategies. HRSA’s responsibilities include increasing testing and prevention among Health Center Program patients, providing access to HIV care and treatment through the RWHAP and Health Center Program, and linking people with HIV, newly diagnosed or re-identified through testing programs, to care, and responding to outbreaks. For the Ryan White Program, the EHE initiative expands the program’s ability to meet the needs of clients, specifically focusing on linking people with HIV who are either newly diagnosed, diagnosed but currently not in care, or are diagnosed and in care but not yet virally suppressed, to the essential HIV care, treatment, and support services needed to help them reach viral suppression.

Eligibility

• RWHAP Part A funded Eligible Metropolitan Area (EMA) or Transitional Grant Area (TGA) whose service area includes one or more of the identified 48 HIV high burden counties; and the EMAs of Washington, D.C. and San Juan, PR.
• RWHAP Part B funded States/Territories identified as having a substantial rural HIV burden–Alabama, Arkansas, Kentucky, Mississippi, Missouri, Oklahoma, and South Carolina.
• The RWHAP Part B Program of the State of Ohio on behalf of Hamilton County.

These types of domestic organizations may apply. “Domestic” means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, or the Republic of Palau.

Grant Title

DoD Alcohol and Substance Use Disorders, Consortium Award

Link

Grant Details

Grant Number

HT942524ASUDRPCA

Grant Funder

Dept. of the Army -- USAMRAA

Current or Forecasted

Current

Funding Type

Cooperative agreement

Funding Amounts

$11,525,000

Expected Number of Awards

Due Date

September 24, 2025

Award Date

Period of Performance

Description

The FY24 ASUDRP CA supports the establishment of a Consortium whose purpose is to identify, evaluate, and advance pharmacotherapies for alcohol, opioid, and other substance use disorders, with an emphasis on other co-occurring mental health conditions, through rigorous, collaborative research efforts that translate basic knowledge and early-stage clinical products into evidence-based treatments. The goal of this research is to maximize functioning and quality of life for Service Members, their Families, Veterans, and the American public.

The proposed research must be relevant to Service Members, Veterans, military beneficiaries, and/or the American public.

Each individual organization must apply to this program announcement as a Consortium Management Core (CMC) by means of a single application, and may also serve as a future research and/or trial site. The CMC will be responsible for coordinating with the Consortium Steering Committee (CSC) and Consortium Executive Committee (CEC) to prioritize, propose, conduct, and analyze basic research and clinical trials, and developing a roadmap to translate basic science knowledge into evidence-based treatments for ASUD. Clinical trials that include military and Veteran populations are encouraged.

Eligibility

Applications may be submitted by foreign or domestic extramural organizations and intramural Department of Defense (DOD) organizations, defined as follows:

• Extramural Organization: An eligible foreign or domestic non-DOD organization. Examples of extramural organizations include, but are not limited to, academic institutions, biotechnology companies, foundations, federal government organizations other than the DOD (i.e., intragovernmental organizations), and research institutes.
• Intramural DOD Organization: Refers specifically to DOD organizations including DOD laboratories, DOD military treatment facilities, and/or DOD activities embedded within a civilian medical center.

Grant Title

Ending the HIV Epidemic in the U.S. – Technical Assistance Provider

Link

Grant Details

Grant Number

HRSA-25-064

Grant Funder

Health Resources & Services Administration (HRSA)

Current or Forecasted

Current

Funding Type

Cooperative agreement

Funding Amounts

$2,000,000

Expected Number of Awards

Five

Due Date

October 22, 2024

Award Date

February 1, 2025

Period of Performance

March 1, 2025, to February 28, 2030 (awarded in five 12-month budget periods)

Description

The overall purpose of this notice of funding opportunity is to undertake a series of activities to support the recipients of Ending the HIV Epidemic in the U.S. – Ryan White HIV/AIDS Program Parts A and B (HRSA-25-063) in meeting the goals of the Ending the HIV Epidemic in the U.S. (hereafter referred to as the “EHE initiative”). The EHE initiative has four key strategies:

• Diagnose
• Treat
• Prevent
• Respond

The Technical Assistance Provider (HRSA-25-064) is responsible for providing technical assistance (TA) to the recipients of HRSA-25-063 on implementation of work plan activities, innovative approaches, and interventions.

HRSA will fund one organization under each announcement to ensure effectiveness and efficiency in the implementation of activities by HRSA-25-063 recipients to support treatment and response activities of the EHE initiative. The intent of the funding opportunity is to maximize the success in developing, implementing, coordinating, and integrating strategies, interventions, approaches, and services to achieve the goals of the EHE initiative. HRSA expects that the recipient(s) of these awards will collaborate to support the recipients of HRSA-25-063. You must apply to the correct announcement number (HRSA-25-064 or HRSA-25-065) that corresponds to the stated activities listed in this section. If you are applying for both announcement numbers, you must submit a separate application for each.

Eligibility

Who can apply:

• Public or nonprofit private entity, including institutions of higher education and academic health science centers involved in addressing HIV related issues on a national scope.
• Faith-based or community-based organization, Tribe, or tribal organization

Types of eligible organizations:

• Public institutions of higher education
• Private institutions of higher education
• Non-profits with or without a 501(c)(3) IRS status
• For-profit organizations, including small businesses
• State, county, city, township, and special district governments, including the District of Columbia, domestic territories, and the freely associated states
• Native American tribal governments
• Native American tribal organizations

These types of domestic organizations may apply. “Domestic” means the 50 states, the District of Columbia, the Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, Guam, the U.S. Virgin Islands, the Federated States of Micronesia, the Republic of the Marshall Islands, or the Republic of Palau.

Grant Title

Drug-Free Communities (DFC) Support Program - NEW (Year 1)

Link

Grant Details

Grant Number

CDC-RFA-CE-25-0114

Grant Funder

Centers for Disease Control (CDC)

Current or Forecasted

Forecasted

Funding Type

Grant

Funding Amounts

$125,000

Expected Number of Awards

100

Due Date

Mar 25, 2025 (estimated)

Award Date

Aug 29, 2025 (estimated)

Start Date

Sep 30, 2025 (estimated)

Description

The Drug-Free Communities (DFC) Support Program was created by the Drug-Free Communities Act of 1997 (Public Law 105-20). The Executive Office of the President, Office of National Drug Control Policy (ONDCP), and the Department of Health and Human Services (HHS), Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control (NCIPC) are accepting applications for Fiscal Year (FY) 2025 Drug-Free Communities (DFC) Support Program grants. The purpose of the DFC Support Program is to establish and strengthen collaboration to support the efforts of community coalitions working to prevent youth substance use. By statute, the DFC Support Program has two goals:

• Establish and strengthen collaboration among communities, public and private non-profit agencies, as well as federal, state, local, and tribal governments to support the efforts of community coalitions working to prevent and reduce substance abuse among youth (individuals 18 years of age and younger).
• Reduce substance abuse among youth and, over time, reduce substance abuse among adults by addressing the factors in a community that increase the risk of substance abuse and promoting the factors that minimize the risk of substance abuse.

Eligibility

• Special district governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Private institutions of higher education
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• City or township governments
• Independent school districts
• Native American tribal organizations (other than Federally recognized tribal governments)
• Native American tribal governments (Federally recognized)
• County governments
• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
• Public and State controlled institutions of higher education
• State governments
• For-profit organizations other than small businesses